ReviewWorld journal of urology2005

Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer.

Martin Gleave et al.PubMed ↗Publisher ↗

No numbers read from the abstract.